Evidence map›Paper›PMID 32850318›Full record

ReviewFrontiers in oncology2020

Optimizing MR-Guided Radiotherapy for Breast Cancer Patients.

Maureen L Groot Koerkamp, Jeanine E Vasmel, Nicola S Russell, Simona F Shaitelman, Carmel N Anandadas, Adam Currey, Danny Vesprini, Brian M Keller, Chiara De-Colle, Kathy Han and 9 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Respiratory navigator-guided multi-slice free-breathing cardiac TPhysics and imaging in radiation oncology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Adaptive radiotherapy for breast cancer.Clinical and translational radiation oncology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 6 countries.

Maureen L Groot KoerkampDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Jeanine E VasmelDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Nicola S RussellDepartment of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Simona F ShaitelmanDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Carmel N AnandadasDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Adam CurreyDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Danny VespriniDepartment of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Brian M KellerDepartment of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Chiara De-ColleDepartment of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany.
Kathy HanDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
Lior Z BraunsteinDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Faisal MahmoodDepartment of Oncology, Odense University Hospital, Odense, Denmark.
Ebbe L LorenzenDepartment of Oncology, Odense University Hospital, Odense, Denmark.
Marielle E P PhilippensDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Helena M VerkooijenImaging Division, University Medical Center Utrecht, Utrecht, Netherlands.
Jan J W LagendijkDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Antonetta C HouwelingDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
H J G Desiree van den BongardDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Anna M KirbyDepartment of Radiotherapy, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom.
University Medical Center Utrecht · NLHealth Sciences Centre · CAMedical College of Wisconsin · USMemorial Sloan Kettering Cancer Center · USOdense University Hospital · DKRoyal Marsden NHS Foundation Trust · GBSunnybrook Health Science Centre · CAThe Christie NHS Foundation Trust · GBThe Netherlands Cancer Institute · NLThe University of Texas MD Anderson Cancer Center · USUniversity of Southern Denmark · DKUniversity of Toronto · CAUniversity of Tübingen · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Cancer Research UK 28284NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (MR)-guided RT, including dedicated MR-guided RT systems [hybrid machines combining an MR scanner with a linear accelerator (MR-linac) or

Indexed as

breast cancerhybrid machinemagnetic resonance imaging (MRI)MR-guided radiotherapyMR-linacneoadjuvant radiation therapypartial breast irradiation

Identifiers

PMID32850318
PMCPMC7399349
OpenAlexW3045528856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.